Kallikrein homologs in snake venoms have been exploited for therapeutic use in the treatment of cardiac and circulatory conditions such as stroke, heart attack, and deep vein thrombosis [165], further emphasising lizard venom kallikreins as having potential for biodiscovery. Here, KLK4 is linked to deep vein thrombosis.